baber/WOPTO huggingface dataset:
Patent FI-20001907-A0 (FI)
Inventor: VEIKKOLAINEN MIKKO
IPC: B23K37/02
Filed: 2000-08-29
Abstract: A method of forming a welded structure (1) comprising arranging on a support surface (2) constituent pieces of the structure to be welded in a desired configuration and welding with welding apparatus (4) the constituent pieces together at a plurality of weld points to form the welded structure (1). The method further comprises recording at least one image of the arrangement of the constituent pieces on the support surface (2), determining from the image(s) the positions of said weld points, and controlling the welding of the constituent pieces with said welding apparatus (4) on the basis of the determined positions of the weld points. The invention also discloses a welding arrangement. <IMAGE>
Patent FI-20022099-A0 (FI)
Inventor: KINNUNEN PERTTI
IPC: F22B37/24
Filed: 2002-11-26
Abstract: A boiler plant, including a combustion section, a heat exchange section including heat exchange surfaces, arranged above the combustion section and having a flow direction from the bottom upwards, and a stationary supporting structure. The combustion section and the heat exchange section are separate chambers, flexibly joined with each other, and the chambers are each separately hung from their upper part to the stationary supporting structure.
Patent FI-20085394-A0 (FI)
Inventor: GROEHN PEKKA TAPANI
Filed: 2008-04-30
Abstract: The object of the invention is a material handling device or crane comprising a support frame with rail wheels, the material handling device or crane comprising a rail support frame (1) for mounting the material handling device movably on rails (2) provided on a foundation, and an upper carriage (4) provided with material handling means (3). The rail support frame (1) comprises two elongated rail units (6a and 6b) provided with rail wheels (5), the rail units being intended to be arranged in the direction of the rails (2), and a transversal intermediate structure (8) interconnecting the elongated rail units (6a and 6b). One of the elongated rail units (6a) is connected to the transversal intermediate structure (8) by means of a pivot joint (9) such, that one of the elongated rail units (6) can turn in a tuning motion in relation to the transversal intermediate structure (8) about such a pivot axis (10), which is essentially parallel to the rotation axes (11) of the rail wheels (5). The material handling device comprises turning motion inhibitor means (12), which are switchable into an inhibiting position for preventing the turning motion of the first elongated rail unit (6a) in relation to the transversal intermediate structure (8), and which, correspondingly, are switchable into a releasing position for enabling the turning motion of the first elongated rail unit (6a) in relation to the transversal intermediate structure (8).
Patent IL-103118-A0 (IL)
Title: Tissue glue prepared by using cryoprecipitate
IPC: A61K35/58
Filed: 1992-09-09
Abstract: A tissue glue is described comprising a component A which comprises a cryoprecipitate of whole blood and a component B comprising a proteolytic enzyme being capable of cleaving specifically fibrinogen present in component A, and causing the formation of a fibrine polymer, in a preferred embodiment component A of the tissue glue comprises 3,000 to 5,000 KIU/ml of aprotinin. In another preferred embodiment component B of the tissue glue is a protease derived from the venom of the South American pit viper. This protease is known under the name batroxobin.
Patent IL-111404-A0 (IL)
Title: 3-aryl-4-alkyl and 4,5-dialkyl-4h-1, 2, 4-triazoles useful as memory enhancers
IPC: C07D249/08
Filed: 1994-10-26
Abstract: This invention relates to the enhancement of memory and cognition and the treatment of Alzheimer's disease and Wernicke-Korsakoff syndrome by administration of 3-aryl-4-alkyl and 4,5-dialkyl-4H-1,2,4-triazoles of formula (I) wherein R1 and R2 independently represent hydrogen, halogen, trifluoromethyl, nitro, C1-4 lower alkyl or C1-4 lower alkoxy, or together, R1 and R2 represent -CH=CH-CH=CH-, forming a 1- or 2-naphthylenyl ring system; R3 represents hydrogen or C1-4 lower alkyl; and R4 represents C1-4 lower alkyl, benzyl, or benzyl substituted by one or two groups selected from halogen, trifluoromethyl, nitro, C1-4 lower alkyl or C1-4 lower alkoxy.
Patent IL-112290-A0 (IL)
Title: Substituted aryl and heteroaryl pyrimidines and herbicidal compositions containing them
IPC: C07D405/04
Filed: 1995-01-10
Abstract: This invention relates to novel aryl and heteroaryl pyrimidine derivatives, shown below, substituted at the 2- and 4-position of the pyrimidine ring, their use as herbicides and agricultural compositions comprising the same. In formula (I), W is a substituted phenyl or a substituted 5- or 6-membered aromatic heterocyclic ring wherein one or two atoms of said ring are selected from oxygen, nitrogen and sulfur; W being substituted by at least R; R is CO2R<4>, CHO, CONH-O-CH2CO2R<4>, COSR<4>, CO2CHR<5>OCOR<6> or CH=NOR<4>; R<1>, R<2>, R<4>, R<5>, R<6> are as defined in the application; m = 1 or 2.
Patent IL-125964-A0 (IL)
Title: Method and apparatus for measuring the thickness of a film particularly of a photoresist film on a semiconductor substrate
IPC: G03F7/26
Filed: 1998-08-27
Abstract: A method or apparatus for measuring lateral variations of a property such as thickness or refractive index of a transparent film on a semiconductor, in a region of repeated patterning comprises: illuminating over the patterned area with a beam of light of multiple wavelengths, the beam having dimensions to include repeated patterning; detecting the intensity of light reflected over the patterned area for each wavelength; producing a signal defining the variation of the intensity of the detected light as a function of the wavelength of the detected light; decomposing the signal into principal frequencies thereof, determining from the principal frequencies, values of the thickness etc. of the transparent film; and applying the values to repetitions within the repeated patterning.
Patent IL-130518-A0 (IL)
Title: Absorbent article having improved integrity and acquisition
IPC: A61F13/15
Filed: 1996-12-20
Abstract: Absorbent articles such as sanitary napkins, panty liners, adult incontinence devices, and the like, that have components that are bonded for improved integrity and an unbonded window on their body-facing side for improved acquisition are disclosed. The absorbent articles comprise a topsheet that is fused to an underlying liquid pervious or absorbent layer at a plurality of individual bonded areas. The absorbent articles have an unbonded window that is substantially free of bonded areas, which is surrounded by regions of the absorbent article that contain bonded areas.
Patent IL-134088-A0 (IL)
Title: Barrier material
IPC: A61L2/20
Filed: 1998-07-13
Abstract: An assembly (10; 110) which has been exposed to ethylene oxide gas comprising an article (3; 103) sterilised by the ethylene oxide gas and a sealed container (6; 106) formed from a laminate having an inner layer which contains a polyolefin, an outer layer which contains a polyester, a polyolefin or a polyamide and an intermediate layer which contains a silicon oxide. The laminate acts to keep the ethylene oxide gas out of the container.
Patent IL-136711-A0 (IL)
Title: Substituted pyridine and pyridazine compounds and their pharmaceutical use
IPC: C07D401/04
Filed: 1998-12-21
Abstract: Selected novel substituted pyridine and pyridazine compounds are effective for prophylaxis and treatment of diseases, such as TNF- alpha , IL-1 beta , IL-6 and/or IL-8 mediated diseases, and other maladies, such as cancer, pain and diabetes. The invention encompasses novel compounds, analogs, prodrugs and pharmaceutically acceptable salts thereof, pharmaceutical compositions and methods for prophylaxis and treatment of diseases and other maladies or conditions involving inflammation, cancer, pain, diabetes and the like. The subject invention also relates to processes for making such compounds as well as to intermediates useful in such processes.
Patent IL-141867-A0 (IL)
Title: 4-aminopyrrolopyrimidines as kinase inhibitors
IPC: A61P19/02
Filed: 1999-09-17
Abstract: Chemical compounds having structural formula (I) and physiologically acceptable salts thereof, are inhibitors of serine/threonine and tyrosine kinase activity. Several of the kinases whose activity is inhibited by these compounds are involved in immunologic, hyperproliferative or angiogenic processes. Thus, these compounds can ameliorate disease states where angiogenesis or endothelial cell hyperproliferative is a factor. These compounds can be used to treat cancer, hyperproliferation disorders, rheumatoid arthritis, disorders of the immune system, transplant rejection, and inflammatory disorders.
Patent IL-146648-A0 (IL)
Title: Interface surface printer
IPC: G06K9/22
Filed: 2000-05-24
Abstract: A method for providing interactivity for printed content is disclosed. An image of a writing surface containing the printed content is captured by an optical imaging pen device. The image includes a pattern printed on the writing surface. A plurality of available options associated with the printed content coincident with the pattern in the image is then determined and a selection from a user of one of the plurality of available options is received. An application is executed, with the execution using the selected option.
Patent IL-151245-A0 (IL)
Title: Foam-forming wound dressing composition
IPC: A61P23/02
Filed: 2001-02-21
Abstract: This invention relates generally to a foamed-wound dressing containing albumin and at least one other protein. The foam dressing is prepared initially as a liquid composition, but forms a foam when a shear force is applied to the liquid. The wound dressing can be prepared as a foam in situ on the surface of the wound or can be pre-formed as a foam and then later applied to a wound. A biocompatible foam wound dressing for human can be prepared using human proteins.
Patent IL-152194-A0 (IL)
Title: A method of detecting a behavior of interest in telecommunication networks
IPC: H04M3/36
Filed: 2002-10-09
Abstract: The application describes a method for detecting a behavior of interest in a surrounding including at least one telecommunication network, by using approach of Immune Engineering. The method comprises steps of analyzing the behavior of interest by building a characterizing data string called DNA which comprises two or more data sub-strings characterizing fragments of the behavior of interest and called genes. Further, there are selected two or more data fragments called detectors and being substantially close to the genes, and the detectors are applied to identify similar to them data fragments if appearing in information concerning real time activity in the surrounding. Based on the identification results, the method detects whether the behavior of interest is present in the newly incoming information. The method is used to detect fraudulent attacks on telecommunications networks. Analysis is performed, based on "historic" information obtained from usage records databases relating to telephone sessions, faxes, data communication, login sessions, bandwidth usage etc. This is used to classify newly incoming usage call records as "normal" or "fraudulent" behavior. <IMAGE>
Patent IL-154993-A0 (IL)
Title: High affinity small molecule c5a receptor modulators
IPC: A61P29/00
Filed: 2000-09-29
Abstract: The invention includes low molecular weight, non-peptidic, non-peptidommetic, organic molecules that can act as modulators of mammalian complement C5a receptors, preferably ones that act as high affinity C5a receptor ligands and also such ligands that can act as antagonists or inverse agonists of complement C5a receptors. Preferred compounds of the invention possess some or all of the following properties in that they are: 1) multi-aryl in structure; 2) heteroaryl in structure; 3) a pharmaceutically acceptable oral dose can provide a detectable in vivo effect; 4) comprise fewer than four or preferably no amide bonds, and 5) capable of habiting leukocyte chemotaxis at nanomolar or sub-nanomolar concentrations. The invention also includes pharmaceutical composition comprising such compounds and the use of such compounds in treating a variety of inflammatory and immune system disorders.
Patent IL-158389-A0 (IL)
Title: A circular needling machine provided with a device for automatically removing preforms
IPC: D04H18/00
Filed: 2002-04-26
Abstract: A machine for needling a textile structure built up from a helical strip delivered by strip supply means, said machine comprising a needling table, a needling head, cutting means for cutting the helical strip, and conical roller drive means for rotating said strip on the needling table, at least a fraction of said conical roller drive means being retractable so as to release an empty space on said needling table enabling ejector means to remove the textile structure from the needling table.
Patent IL-158820-A0 (IL)
Title: Insertion chute
IPC: B65F5/00
Filed: 2002-05-24
Abstract: The present invention relates to an insertion chute (1) of the separate type. An upper chute portion (3) of such an insertion chute is made at least essentially independent of the chute discharge valve (7) and its operation by directly or indirectly attaching not only the chute discharge valve but also a valve operating means (9) exclusively to the lower chute portion. Accordingly, the invention offers flexibility both with regard to the upper, normally visible chute portion and to the lower chute portion that is normally hidden and that may be called upon to serve as an expanded temporary storage space.
Patent IL-160545-A0 (IL)
Title: (-)-1-(3,4-dichlorophenyl) -3- azabicyclo [3.1.0] hexane, compositions thereof and uses as a dopamine-reuptake inhibitor
IPC: A61P3/04
Filed: 2002-08-14
Abstract: A new polymorphic crystalline form of bicifadine hydrochloride, designated form B, which is more thermodynamically stable than the previously known polymorphic form of bicifadine hydrochloride, designated as form A, methods for preparing said crystalline form B and pharmaceutical compositions containing said crystalline form B.
Patent IL-164330-A0 (IL)
Title: Intervertebral prosthesis or nucleus replacement prosthesis
IPC: A61F2/44
Filed: 2002-04-04
Abstract: An intervertebral disk prosthesis or nuclear prosthesis ( 1 ) includes a longitudinal, flexibility-yielding object ( 2 ) that can be spiral-wound ( 2 ), with a first exterior end ( 3 ), a second interior end ( 4 ) and a longitudinal central axis ( 5 ). The cross-section ( 10 ) of the object ( 2 ), which is orthogonal towards the central axis ( 5 ), is reduced in size towards the second interior end ( 4 ).
Patent IL-173285-A0 (IL)
Title: Dispensing container
IPC: G01F11/28
Filed: 2006-01-22
Abstract: A dispensing container (1) comprising; a main bottle (2) having an outlet port (6) for the fluid product located at the bottom (21); thereof; a metering receptacle (3), having a side port (7; 70) for inletting the fluid product and a top opening (8) for outwardly dispensing the fluid product; and a duct (4), having an internal lumen (12) connecting the outlet port (6) of the main bottle (2) to the inlet port (7) of the metering receptacle (3), wherein the main bottle (2) is of the type apt to be deformed to express the fluid product into the metering receptacle (3) through the duct (4), and wherein the internal lumen (12) of the duct (4) comprises, at the inlet port (7) of the metering receptacle (3), an end portion (121, 1210) having a frustum of cone development and a cross section increasing toward the inlet port (7).
Patent IL-174446-A0 (IL)
Title: 2,4-dioxo-3-quinazolinylaryl sulfonylurea derivatives and pharmaceutical compositions containing the same
IPC: C07D409/12
Filed: 2006-03-21
Abstract: 2,4-Dioxo-3-quinazolinylaryl sulfonylurea compounds having the formula: wherein R is a member selected from the group consisting of H and C<SUB>1-6 </SUB>alkyl; R<SUP>1 </SUP>is a member selected from the group consisting of H, C<SUB>1-6 </SUB>alkyl, C<SUB>1-6 </SUB>haloalkyl, C<SUB>3-5 </SUB>cycloalkyl and C<SUB>3-5 </SUB>cycloalkyl-alkyl; R<SUP>2 </SUP>is a member selected from the group consisting of H, halogen, C<SUB>1-6 </SUB>alkyl, C<SUB>2-6 </SUB>alkenyl, C<SUB>2-6 </SUB>alkynyl, C<SUB>1-6 </SUB>haloalkyl, C<SUB>1-6 </SUB>alkoxy, cyano and -C(O)R<SUP>2a</SUP>, wherein R<SUP>2a </SUP>is a member selected from the group consisting of C<SUB>1-6 </SUB>alkoxy and (C<SUB>1-6 </SUB>alkyl)<SUB>0-2 </SUB>amino; L is a 1 to 3 carbon linking group selected from the group consisting of -CH<SUB>2</SUB>-, -CH(CH<SUB>3</SUB>)-, -CH<SUB>2</SUB>CH<SUB>2</SUB>-, -CH<SUB>2</SUB>CH(CH<SUB>3</SUB>)- and -CH<SUB>2</SUB>CH<SUB>2</SUB>CH<SUB>2</SUB>-; L<SUP>1 </SUP>is a linking group selected from the group consisting of a bond and -CH<SUB>2</SUB>-; L<SUP>2 </SUP>is a linking group selected from the group consisting of a bond, -NH- and -CH<SUB>2</SUB>-; and Ar<SUP>1 </SUP>is an aromatic ring selected from the group consisting of benzene, pyridine and pyrimidine; are provided. The compounds are useful for the inhibition of ADP-platelet aggregation, particularly in the treatment of thrombosis and thrombosis related conditions or disorders.
Patent IL-176338-A0 (IL)
Title: Serum-free vero cell banking process
IPC: C12N5/00
Filed: 2006-06-15
Abstract: A serum-free Vero cell banking process provides a standardized and consistent way to generate reliable and stable cell banks for viral vaccine production. The substitution of animal-derived substances with plant-derived substances in the growth and freezing media increases the viability of the cells upon thawing and reduces their recovery time, thereby allowing a more precise schedule for manufacturing and more consistent processes.
Patent IL-177779-A0 (IL)
Title: Multi- atate alarm system for a medical pump
IPC: A61M5/168
Filed: 2006-08-30
Abstract: A method of notification via an alarm system (52, 352) associated at least one treatment parameter for delivering a therapeutic fluid (54) to a patient is described. The method comprising the steps of enabling first (208) and second (206) alarm states of the alarm system, the second alarm state discernable from the first alarm state. The first alarm state is activated upon occurrence of a first event and a snooze element (200) is enabled that when activated enables the second alarm state to be activated upon occurrence of a second event. The second alarm state is then activated upon occurrence of the second event.
Patent IL-182062-A0 (IL)
Title: Methods and computer program products for analysis and optimization of marker candidates for cancer prognosis
IPC: G16B20/00
Filed: 2007-03-20
Abstract: Methods and computer program products for evaluating and optimizing one or more markers for use in establishing a prognosis for a patient suffering from a disease are provided. More particularly, the methods include steps for systematically evaluating a number of features that may be extracted from an image of a body sample, such as a histological slide, that has been exposed to one or more biomarkers so as to establish a prognostic decision rule based on one or more of the extracted features such that the decision rule yields a prognosis that is optimally predictive of actual patient outcome. Thus, the methods and computer program products provided yield optimally predictive prognoses to assist clinicians in developing strategies for effective patient care management.
Patent IL-193146-A0 (IL)
Title: High power, polarization-diverse cloverleaf phased array
Filed: 2008-07-30
Abstract: A phased array antenna includes a substrate, and multiple radiating elements conformally mounted as micro-strip on the substrate. Each of the radiating elements is of a triangular shape, and four of the radiating elements are arranged to form a crossed bowtie cloverleaf radiator. In addition, the four radiating elements form two pairs of radiating elements, and the two pairs of radiating elements are orthogonal to each other. The radiating elements are disposed on a front surface of the substrate, and a RF center conductor is orthogonally oriented toward a rear surface of the substrate and connected to one of the radiating elements for feeding a RF signal to the one radiating element.
Patent IL-202757-A0 (IL)
Title: Nicotinamide derivatives as synthesis units for producing agrochemical substances, and method for the production thereof
Filed: 2009-12-15
Abstract: The nicotinamide compounds are new. The nicotinamide compound having general formula (I), preferably general formula (II), is new. In general formula (I), X 1>F, Cl, Br, I, SCN or S-R 3>, where R 3>=H, 1-6C alkyl, 3-6C cycloalkyl, -(CH 2) r-C 6H 5, where r=0-6, where the alkyl residue -(CH 2) r is substituted.; R 1>halogen, cyano, thiocyanato or halogen is substituted with alkyl, alkenyl, alkinyl, alkoxy, alkylthio, alkylsulfinyl, alkylsulfonyl, alkylamino, alkylcarbonyl, alkoxycarbonyl, alkylaminocarbonyl, aryl, heteroaryl, cycloalkyl or heterocyclyl, where the alkyl and alkylene has 1-6C, alkenyl and alkinyl containing 2-6C, cycloalkyl contains 3-6C atoms and the aryl group has 6-10C; n : 0-2, preferably 0-1, particularly 0; R 2>1-6C alkyl, 2-6C alkenyl, 2-6C alkinyl, 3-6C cycloalkyl, which is substituted single or multiple times, directly or differently with halogen, cyano, nitro, 1-4C alkoxy, 1-4C haloalkoxy, 1-4C alkylthio, 1-4C alkylsulfinyl, 1-4C alkylsulfonyl, (1-6C alkoxy)carbonyl, (1-6C alkyl)carbonyl or 3-6C trialkylsilyl; and m : 0-4, preferably 0-2, particularly 0. In general formula (II),R 1>,R 2>,m and n=same as variable group R 1>,R 2>,m and n of general formula (I). Independent claims are included for: (1) a method for producing a nicotinamide compound; and (2) a method for producing a compound of general formula (III), which involves converting a hydroxamic acid compound of general formula (IV) with ethylene oxide of general formula (V) in water and acetone, methanol, ethanol, N,N-dimethylformamide or acetonitrile. R : aromatic, cyclic, heteroaromatic, heterocyclic or aliphatic organic residue; and R 2> and m : same as variable group R 2> and m of general formula (I). [Image] [Image] [Image] [Image] [Image].
Patent RO-130591-A0 (RO)
Title: Set of biomarkers for diagnosis and prognosis of cervical cancer, obtained by studying the proteomic profile
Inventor: CODRICI ELENA
IPC: G01N33/574
Filed: 2014-04-03
Abstract: The invention relates to a method of identifying a set of biomarkers useful in the diagnosis and prognosis of cervical cancer. According to the invention, the method comprises the analysis of the proteomic profile in a tumoral-pathological tissue in relation with a peritumoral-normal tissue from which a set of protein biomarkers was identified, where the molecular weight varies in the range of 15...50 kDa, with pI 5.5...7.5, namely : CDK4 with a molecular weight of 33 kDa and pI 6.66, cycline B1 with a molecular weight of 48 kDa and pI 7.1, p16with a molecular weight of 16 kDa and pI 5.5 intended to be used as an instrument of prognosis and diagnosis for cervical cancer at the molecular level.